Skip Navigation

Cardiovascular Research 2000 46(1):102-110; doi:10.1016/S0008-6363(99)00428-9
© 2000 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Spitznagel, H.
Right arrow Articles by Unger, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spitznagel, H.
Right arrow Articles by Unger, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2000, European Society of Cardiology

Cardioprotective effects of the Na+/H+-exchange inhibitor cariporide in infarct-induced heart failure

Heidi Spitznagela, Oliver Chunga, Qin-Gui Xiaa, Birthe Rossiusa, Sascha Illnera, Gunnar Jähnichena, Steffen Sandmanna, Alexander Reineckea, Mat J.A.P. Daemenb and Thomas Ungera,*

aInstitute of Pharmacology, Christian-Albrechts-University Kiel, Hospitalstrasse 4, D-24105 Kiel, Germany
bDepartment of Pathology, Maastricht University, Maastricht, The Netherlands

* Corresponding author. Tel.: +49-431-597-3500; fax: +49-431-597-3522 th.unger{at}pharmakologie.uni-kiel.de

Objective: We investigated the effect of chronic treatment with the new Na+/H+-exchange inhibitor, cariporide, on cardiac function and remodelling 6 weeks after myocardial infarction (MI) in rats. Methods: Treatment with cariporide was commenced either 1 week pre or 30 min, 3 h, 24 h or 7 days after ligation of the left ventricular artery and was continued until haemodynamic parameters were obtained 6 weeks after MI in conscious rats. Results: Compared to sham animals, untreated MI-controls developed pronounced heart failure after 6 weeks. Basal left ventricular end-diastolic pressure (in mmHg) was reduced in the groups in which cariporide was started 1 week pre (16.0±1.7) or 30 min (12.5±1.1), 3 h (11.8±1.0) and 24 h (13.0±2.5) after MI compared to untreated MI-controls (22.4±1.5; P<0.01). Basal myocardial contractility (in 1000 mmHg/s) was only increased when treatment was initiated after 30 min (9.0±0.7), 3 h (8.5±0.3) and 24 h (8.0±0.7) compared to untreated MI-controls (5.8±0.7; P<0.05–0.01). Infarct size (in % of left ventricular circumference) was 40.0±2.1 in MI-controls and was decreased when treatment was begun after 30 min (32.6±2.7) or 3 h (32.4±2.3) (P<0.05). In animals, in which cariporide was started 3 h after induction of MI, heart weight/body weight ratio was significantly decreased, indicating reduced cardiac hypertrophy. When treatment started 7 days after MI, cariporide did not exert any beneficial actions on structural and functional cardiac parameters. Conclusion: Our results show for the first time that chronic treatment with the Na+/H+-exchange inhibitor cariporide engendered marked cardioprotective effects when commenced before and up to 24 h after MI. The optimal time for the start of treatment was between 30 min and 3 h post MI.

KEYWORDS NHE, Na+/H+-exchanger; MI, myocardial infarction; LVP, left ventricular pressure; LVEDP, left ventricular end-diastolic pressure; dP/dtmax, myocardial contractility; MAP, mean arterial pressure; HR, heart rate; Car, cariporide; THW/BW, total heart weight to body weight ratio; IS, infarct size; nIML, non infarcted muscle length; mLVC, mean left ventricular circumference; dLV, inner left ventricular diameter; aS, average septal thickness


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CirculationHome page
M. Wakeno, T. Minamino, O. Seguchi, H. Okazaki, O. Tsukamoto, K.-i. Okada, A. Hirata, M. Fujita, H. Asanuma, J. Kim, et al.
Long-Term Stimulation of Adenosine A2b Receptors Begun After Myocardial Infarction Prevents Cardiac Remodeling in Rats
Circulation, October 31, 2006; 114(18): 1923 - 1932.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Javadov, D. M. Purdham, A. Zeidan, and M. Karmazyn
NHE-1 inhibition improves cardiac mitochondrial function through regulation of mitochondrial biogenesis during postinfarction remodeling
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1722 - H1730.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Javadov, D. Baetz, V. Rajapurohitam, A. Zeidan, L. A. Kirshenbaum, and M. Karmazyn
Antihypertrophic Effect of Na+/H+ Exchanger Isoform 1 Inhibition Is Mediated by Reduced Mitogen-Activated Protein Kinase Activation Secondary to Improved Mitochondrial Integrity and Decreased Generation of Mitochondrial-Derived Reactive Oxygen Species
J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1036 - 1043.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Baartscheer, C. A. Schumacher, M. M.G.J. van Borren, C. N.W. Belterman, R. Coronel, T. Opthof, and J. W.T. Fiolet
Chronic inhibition of Na+/H+-exchanger attenuates cardiac hypertrophy and prevents cellular remodeling in heart failure
Cardiovasc Res, January 1, 2005; 65(1): 83 - 92.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Avkiran and R. S Haworth
Regulatory effects of G protein-coupled receptors on cardiac sarcolemmal Na+/H+ exchanger activity: signalling and significance
Cardiovasc Res, March 15, 2003; 57(4): 942 - 952.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A Baartscheer, C.A Schumacher, M.M.G.J van Borren, C.N.W Belterman, R Coronel, and J.W.T Fiolet
Increased Na+/H+-exchange activity is the cause of increased [Na+]i and underlies disturbed calcium handling in the rabbit pressure and volume overload heart failure model
Cardiovasc Res, March 15, 2003; 57(4): 1015 - 1024.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. P. Loennechen, U. Wisloff, G. Falck, and O. Ellingsen
Effects of Cariporide and Losartan on Hypertrophy, Calcium Transients, Contractility, and Gene Expression in Congestive Heart Failure
Circulation, March 19, 2002; 105(11): 1380 - 1386.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. K Snabaitis, D. J Hearse, and M. Avkiran
Regulation of sarcolemmal Na+/H+ exchange by hydrogen peroxide in adult rat ventricular myocytes
Cardiovasc Res, February 1, 2002; 53(2): 470 - 480.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. Sandmann, M. Yu, E. Kaschina, A. Blume, E. Bouzinova, C. Aalkjaer, and T. Unger
Differential effects of angiotensin AT1 and AT2 receptors on the expression, translation and function of the Na+-H+ exchanger and Na+-HCO3- symporter in the rat heart after myocardial infarction
J. Am. Coll. Cardiol., June 15, 2001; 37(8): 2154 - 2165.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. R. Knight, A. H. Smith, D. M. Flynn, J. T. MacAndrew, S. S. Ellery, J. X. Kong, R. B. Marala, R. T. Wester, A. Guzman-Perez, R. J. Hill, et al.
A Novel Sodium-Hydrogen Exchanger Isoform-1 Inhibitor, Zoniporide, Reduces Ischemic Myocardial Injury in Vitro and in Vivo
J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 254 - 259.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Kusumoto, J. V. Haist, and M. Karmazyn
Na+/H+ exchange inhibition reduces hypertrophy and heart failure after myocardial infarction in rats
Am J Physiol Heart Circ Physiol, February 1, 2001; 280(2): H738 - H745.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Q.-G. Xia, O. Chung, H. Spitznagel, S. Illner, G. Janichen, B. Rossius, P. Gohlke, and T. Unger
Significance of timing of angiotensin AT1 receptor blockade in rats with myocardial infarction-induced heart failure
Cardiovasc Res, January 1, 2001; 49(1): 110 - 117.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.